Provided by Tiger Trade Technology Pte. Ltd.

BioCardia

1.47
+0.02001.38%
Pre-market: 1.46-0.0100-0.68%08:02 EST
Volume:64.90K
Turnover:95.67K
Market Cap:15.60M
PE:-0.89
High:1.50
Open:1.48
Low:1.45
Close:1.45
52wk High:3.20
52wk Low:1.00
Shares:10.61M
Float Shares:4.05M
Volume Ratio:0.82
T/O Rate:1.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6599
EPS(LYR):-2.8960
ROE:-317.47%
ROA:-86.45%
PB:5.94
PE(LYR):-0.51

Loading ...

BioCardia to Host Q3 2025 Corporate Update and Financial Results Conference Call on November 12, 2025

GlobeNewswire
·
Nov 06

BioCardia Inc. Announces Date for Upcoming Annual Stockholders Meeting

Reuters
·
Nov 03

BioCardia Enrolls First Patient in Phase 3 CardiAMP HF II Cell Therapy Trial

Reuters
·
Oct 30

BioCardia Announces University of Wisconsin Enrolls Their First Patient in Phase 3 Cardiamp HF Ii Cell Therapy Pivotal Trial

THOMSON REUTERS
·
Oct 30

BioCardia’s Innovative Stem Cell Therapy Trial for Heart Failure: Key Updates and Market Impact

TIPRANKS
·
Oct 28

BioCardia, Inc. - 424B5

THOMSON REUTERS
·
Oct 25

BioCardia Sets Record Date for Annual Meeting

TIPRANKS
·
Oct 08

BioCardia Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire
·
Oct 02

IPS, Inc. Partners with BCDA to Boost Luzon Island’s Digital Infrastructure

TIPRANKS
·
Sep 30

BioCardia Inc. Granted Nasdaq Extension After Falling Below Stockholders’ Equity Listing Requirement

Reuters
·
Sep 24

BioCardia Executives Make Bold Moves with Major Stock Purchases

TIPRANKS
·
Sep 24

Analysts Conflicted on These Healthcare Names: Alector (ALEC), Nurix Therapeutics (NRIX) and BioCardia (BCDA)

TIPRANKS
·
Sep 24

BioCardia Inc. CEO Peter Altman Reports Acquisition of Common Shares

Reuters
·
Sep 24

BioCardia Inc. Raises $5.1 Million Through Sale of Common Stock and Warrants in Recent Offering

Reuters
·
Sep 23

BioCardia Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 23

BioCardia’s Positive Consultation with Japan’s PMDA

TIPRANKS
·
Sep 22

BioCardia: Completing Responses to Japan's Pmda's Questions & Anticipates Formal Clinical Consultation Near End of Year

THOMSON REUTERS
·
Sep 22

BioCardia Announces Positive Preliminary Clinical Consultation with Japan Pharmaceutical and Medical Device Agency on Cell Therapy for Ischemic Heart Failure

GlobeNewswire
·
Sep 22

Insiders' US$1.06m Investments In Red Following BioCardia's US$117k Dip In Market Value

Simply Wall St.
·
Sep 20

BioCardia Raises $5.1 Million Through Stock Sale

TIPRANKS
·
Sep 20